BeCoMe-9: A Clinical Study of BE-101 for the Treatment of Adults With Moderately Severe or Severe Hemophilia B
Clinical trial NCT06611436 · TERMINATED
Trial details
- NCT number
- NCT06611436
- Sponsor
- Be Biopharma
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-04
- Primary completion
- 2026-05-29
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.